Treatments for Post-traumatic Stress Disorder: Pharmaceutical and Electrophysiologic Considerations

Opinion statement Most individuals who experience traumatic events remain asymptomatic or symptoms resolve quickly, but in a minority who develop post-traumatic stress disorder (PTSD), symptoms can persist for decades and can be associated with psychiatric and medical co-morbidities and poor social...

Full description

Saved in:
Bibliographic Details
Published in:Current treatment options in psychiatry 2015-03, Vol.2 (1), p.73-85
Main Authors: Baker, Dewleen G., Lerman, Immanuel, Espejo, Emmanuel P., McLay, Robert
Format: Article
Language:English
Subjects:
Bipolar disorder
Clinical trials
Disease
Drug therapy
Extinction (Learning)
Medicine
Medicine & Public Health
Memory
Mental disorders
Neural networks
Neurology
Neurosciences
Pathology
Pharmaceuticals
Physiology
Post traumatic stress disorder
Post-Traumatic Stress Disorders (T Geracioti and K Chard
Proteins
Psychiatry
Psychotropic drugs
Section Editors
Topical Collection on Post-Traumatic Stress Disorders
Trauma
Veterans
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Opinion statement Most individuals who experience traumatic events remain asymptomatic or symptoms resolve quickly, but in a minority who develop post-traumatic stress disorder (PTSD), symptoms can persist for decades and can be associated with psychiatric and medical co-morbidities and poor social and occupational functioning. Currently, first-line pharmacotherapies are selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for core symptoms and in individuals with unremitting nightmares, prazosin, is commonly used and often effective. This review appraises these commonly used evidence-based treatments and their conceptual underpinnings. It follows with a discussion of concepts underlying emerging treatment research and development, in particular the use of combined psychotherapeutic-pharmacologic approaches and electro-physiological technologies that stimulate neural circuits and their potential uses. While the evidence for combined psychotherapy and either pharmacological or physiological treatments is only now emerging, some of these modalities appear promising.
ISSN:2196-3061
2196-3061
DOI:10.1007/s40501-015-0035-8